Atezolizumab Plus Nab-paclitaxel in PD-L1-Positive TNBC-Letter

Clin Cancer Res. 2020 Jul 15;26(14):3892-3893. doi: 10.1158/1078-0432.CCR-20-0668.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Albumins
  • Antibodies, Monoclonal, Humanized
  • B7-H1 Antigen*
  • Humans
  • Paclitaxel
  • Triple Negative Breast Neoplasms*

Substances

  • 130-nm albumin-bound paclitaxel
  • Albumins
  • Antibodies, Monoclonal, Humanized
  • B7-H1 Antigen
  • atezolizumab
  • Paclitaxel